Kymera Therapeutics, Inc. - Common Stock — 재무제표 (NASDAQ:KYMR) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 487.18 M605.9 M603.13 M575.76 M978.03 M1.74 B 총 부채 203.29 M146.27 M112.98 M180.79 M142.42 M163.15 M 자본금 총액 283.89 M459.64 M490.15 M394.97 M835.62 M1.58 B 총 부채 및 주주자본 487.18 M605.9 M603.13 M575.76 M978.03 M1.74 B 총부채 —————— 순부채 ——————

뉴스

Kymera Therapeutics, Inc. (KYMR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Kymera Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:KYMR) 2026-05-04

KYMR Q1 Earnings Top Estimates, Revenues Gain on GILD Collaboration

Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Tops Revenue Estimates

Wave Life Sciences (WVE) Reports Q1 Loss, Beats Revenue Estimates

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

Kymera, 약물 개발 전략 인사이트 제시

Kymera at Leerink Global Healthcare: Strategic Insights on Drug Development

Kymera, 아토피 피부염 임상 시험 데이터 AAD 학회서 발표

Kymera to present atopic dermatitis trial data at AAD meeting